Works matching DE "RALTEGRAVIR"

Results: 560

Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient.

Published in:

2016

By:

Cattaneo, Dario;
Sollima, Salvatore;
Charbe, Nitin;
Resnati, Chiara;
Clementi, Emilio;
Gervasoni, Cristina

Publication type:

Letter

Pharmacokinetic and safety of raltegravir in pregnancy.

Published in:

2012

By:

Croci, Leonardo;
Trezzi, Michele;
Allegri, Maria;
Carli, Tiziana;
Chigiotti, Silvia;
Riccardi, Maria;
Ricciardi, Barbara;
Toti, Mario;
Nencioni, Cesira

Publication type:

Letter

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens.

Published in:

HIV Medicine, 2018, v. 19, n. 2, p. 102, doi. 10.1111/hiv.12557

By:

the EuroSIDA Study Group;
Cozzi‐Lepri, A.;
Mocroft, A.;
Yust, I.;
Schmid, P.;
Gottfredsson, M.;
Khromova, I.;
Jilich, D.;
Flisiak, R.;
Smidt, J.;
Rozentale, B.;
Radoi, R.;
Zangerle, R.;
Losso, M. H.;
Machala, L.;
Zilmer, K.;
Ristola, M.;
Pradier, C.;
Kirk, O.;
Lundgren, J. D.

Publication type:

Article

Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.

Published in:

HIV Medicine, 2017, v. 18, n. 7, p. 474, doi. 10.1111/hiv.12478

By:

Calza, L;
Colangeli, V;
Magistrelli, E;
Bussini, L;
Conti, M;
Ramazzotti, E;
Mancini, R;
Viale, P

Publication type:

Article

Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.

Published in:

HIV Medicine, 2017, v. 18, n. 1, p. 56, doi. 10.1111/hiv.12468

By:

Hoffmann, C;
Welz, T;
Sabranski, M;
Kolb, M;
Wolf, E;
Stellbrink, H‐J;
Wyen, C

Publication type:

Article

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.

Published in:

HIV Medicine, 2014, v. 15, n. 7, p. 431, doi. 10.1111/hiv.12128

By:

Lake, JE;
McComsey, GA;
Hulgan, T;
Wanke, CA;
Mangili, A;
Walmsley, SL;
Stramotas, SA;
Tracy, R;
Currier, JS

Publication type:

Article

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks.

Published in:

HIV Medicine, 2014, v. 15, n. 6, p. 373, doi. 10.1111/hiv.12123

By:

Bloch, M;
Tong, WWY;
Hoy, J;
Baker, D;
Lee, FJ;
Richardson, R;
Carr, A

Publication type:

Article

Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.

Published in:

HIV Medicine, 2014, v. 15, n. 1, p. 13, doi. 10.1111/hiv.12075

By:

McAllister, J;
Read, P;
McNulty, A;
Tong, WWY;
Ingersoll, A;
Carr, A

Publication type:

Article

Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients Pharmacokinetics of the combination raltegravir/atazanavir in HIV-1-infected patients.

Published in:

HIV Medicine, 2013, v. 14, n. 7, p. 449, doi. 10.1111/hiv.12029

By:

Jansen, A;
Colbers, EPH;
Ven, AJAM;
Richter, C;
Rockstroh, JK;
Wasmuth, JC;
Luin, M;
Burger, DM

Publication type:

Article

Longitudinal analysis of integrase N155 H variants in heavily treated patients failing raltegravir-based regimens.

Published in:

HIV Medicine, 2013, v. 14, n. 2, p. 85, doi. 10.1111/j.1468-1293.2012.01039.x

By:

Nguyen, HL;
Charpentier, C;
Nguyen, N;
Truchis, P;
Molina, J ‐ M;
Ruxrungtham, K;
Delaugerre, C

Publication type:

Article

Safety and efficacy of raltegravir in patients with HIV-1 and hepatitis B and/or C virus coinfection.

Published in:

HIV Medicine, 2012, v. 13, n. 2, p. 127, doi. 10.1111/j.1468-1293.2011.00933.x

By:

Rockstroh, JK;
Teppler, H;
Zhao, J;
Sklar, P;
Harvey, CM;
Strohmaier, KM;
Leavitt, RY;
Nguyen, B-YT

Publication type:

Article

UV -- SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF RALTEGRAVIR IN BULK AND TABLET DOSAGE FORM.

Published in:

International Journal of Pharmaceutical, Chemical & Biological Sciences, 2014, v. 4, n. 4, p. 807

By:

Siddartha, B.;
Babu, I. Sudheer

Publication type:

Article

Raltegravir in HIV-1 Infection: Safety and Efficacy in Treatment-Naïve Patients.

Published in:

Clinical Medicine Reviews in Therapeutics, 2012, v. 4, p. 13, doi. 10.4137/CMRT.S5022

By:

Pandey, Krishan K.

Publication type:

Article

Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.

Published in:

2018

By:

Charpentier, Charlotte;
Malet, Isabelle;
Andre-Garnier, Elisabeth;
Storto, Alexandre;
Bocket, Laurence;
Amiel, Corinne;
Morand-Joubert, Laurence;
Tumiotto, Camille;
Nguyen, Thuy;
Maillard, Anne;
Rodallec, Audrey;
Leoz, Marie;
Montes, Brigitte;
Schneider, Véronique;
Plantier, Jean-Christophe;
Dina, Julia;
Pallier, Coralie;
Mirand, Audrey;
Roussel, Catherine;
Signori-Schmuck, Anne

Publication type:

journal article

Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.

Published in:

2018

By:

Pressiat, Claire;
Hirt, Déborah;
Treluyer, Jean-Marc;
Zheng, Yi;
Morlat, Philippe;
Naqvi, Alice;
Tran, Laurent;
Viard, Jean-Paul;
Avettand-Fenoel, Véronique;
Rouzioux, Christine;
Meyer, Laurence;
Cheret, Antoine;
OPTIPRIM Study Group

Publication type:

journal article

Implications of integrase inhibitors for HIV-infected transplantation recipients: Raltegravir and dolutegravir (S/GSK 1349572).

Published in:

BioScience Trends, 2011, v. 5, n. 5, p. 189, doi. 10.5582/bst.2011.v5.5.189

By:

Waki, Kayo;
Sugawara, Yasuhiko

Publication type:

Article

HIV drug may have additional application as herpes virus replication inhibitor.

Published in:: Expert Review of Clinical Pharmacology, 2010, v. 3, n. 6, p. 719
Publication type:: Article

Assessment of risk factors for virological nonsuppression following switch to dolutegravir and lamivudine, or bictegravir, emtricitabine, and tenofovir alafenamide fumarate in a real-world cohort of treatment-experienced adults living with HIV.

Published in:

PLoS ONE, 2024, v. 19, n. 11, p. 1, doi. 10.1371/journal.pone.0314003

By:

Lee, Shu-Yuan;
Lin, Yi-Chun;
Chen, Cheng-Pin;
Cheng, Shu-Hsing;
Chang, Shu-Ying;
Ku, Shin-Yen;
Cheng, Chien-Yu

Publication type:

Article

Viral load suppression and HIV-1 drug resistance mutations in persons with HIV on TLD/TAFED in Zambia.

Published in:

PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0308869

By:

Luwaya, Emmanuel L.;
Mwape, Lackson;
Bwalya, Kaole;
Siakabanze, Chileleko;
Hamooya, Benson M.;
Masenga, Sepiso K.

Publication type:

Article

Determinants of virological failure among HIV clients on second-line antiretroviral treatment at Felege-hiwot and University of Gondar comprehensive specialized hospitals in the Amhara Region, Northwest Ethiopia: A case-control study.

Published in:

PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0289450

By:

Ayenew, Getahun;
Agumas, Yeshambel;
Shibabaw, Tebkew;
Getaneh, Gebremariam;
Getie, Michael

Publication type:

Article

Observational study of effects of HIV acquisition and antiretroviral treatment on biomarkers of systemic immune activation.

Published in:

PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0288895

By:

Kosmider, Ewelina;
Wallner, Jackson;
Gervassi, Ana;
Bender Ignacio, Rachel A.;
Pinto-Santini, Delia;
Gornalusse, German;
Pandey, Urvashi;
Hladik, Florian;
Edlefsen, Paul T.;
Lama, Javier R.;
Duerr, Ann C.;
Frenkel, Lisa M.

Publication type:

Article

Incidence of lost to follow up among HIV-positive children on antiretroviral therapy in Ethiopia: Systematic review and meta-analysis.

Published in:

PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0304239

By:

Girma, Desalegn;
Abita, Zinie;
Lemu, Lidya Gutema;
Asmelash, Daniel;
Bambo, Getachew Mesfin;
Alie, Melesew Setegn;
Abebe, Gossa Fetene

Publication type:

Article

Prevalence, treatment, and factors associated with cryptococcal meningitis post introduction of integrase inhibitors antiretroviral based regimens among People Living with HIV in Tanzania.

Published in:

PLoS ONE, 2024, v. 19, n. 2, p. 1, doi. 10.1371/journal.pone.0294940

By:

Minja, Makyao;
Mbilinyi, Tusaligwe;
Mkinga, Bryceson;
Philipo, Erick G.;
Owenya, Joyce;
Kilonzi, Manase

Publication type:

Article

Effectiveness, durability and safety of dolutegravir and lamivudine versus bictegravir, emtricitabine and tenofovir alafenamide in a real-world cohort of HIV-infected adults.

Published in:

PLoS ONE, 2023, v. 18, n. 9, p. 1, doi. 10.1371/journal.pone.0291480

By:

Mendoza, Inés;
Lázaro, Alicia;
Espinosa, Alfredo;
Sánchez, Lorenzo;
Horta, Ana María;
Torralba, Miguel

Publication type:

Article

Plasma Concentrations of Rosmarinic Acid in Patients on Antiretroviral Therapy: In Silico Exploration Based on Clinical Data.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2230, doi. 10.3390/ijms25042230

By:

Hitl, Maja;
Pavlović, Nebojša;
Brkić, Snežana;
Dragović, Gordana;
Srđenović-Čonić, Branislava;
Kladar, Nebojša

Publication type:

Article

The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario.

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12187, doi. 10.3390/ijms241512187

By:

Renzi, Gioele;
Carta, Fabrizio;
Supuran, Claudiu T.

Publication type:

Article

Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds.

Published in:

2023

By:

Moranguinho, Inês;
Taveira, Nuno;
Bártolo, Inês

Publication type:

Literature Review

High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14300, doi. 10.3390/ijms232214300

By:

Bártolo, Inês;
Moranguinho, Inês;
Gonçalves, Paloma;
Diniz, Ana Rita;
Borrego, Pedro;
Martin, Francisco;
Figueiredo, Inês;
Gomes, Perpétua;
Gonçalves, Fátima;
Alves, Américo J. S.;
Alves, Nuno;
Caixas, Umbelina;
Pinto, Inês V.;
Barahona, Isabel;
Pinho e Melo, Teresa M. V. D.;
Taveira, Nuno

Publication type:

Article

Genetic Analysis of HIV-1 Integrase Sequences from Treatment Naive Individuals in Northeastern South Africa.

Published in:

International Journal of Molecular Sciences, 2013, v. 14, n. 3, p. 5013, doi. 10.3390/ijms14035013

By:

Bessong, Pascal Obong;
Nwobegahay, Julius

Publication type:

Article

Incidence and risk factors for liver enzymes elevations in highly treatment-experienced patients switching from enfuvirtide to raltegravir: a sub-study of the ANRS-138 EASIER trial.

Published in:

AIDS Research & Therapy, 2016, p. 1, doi. 10.1186/S12981-016-0101-3

By:

de Castro, Nathalie;
Braun, Joséphine;
Charreau, Isabelle;
Lafeuillade, Alain;
Viard, Jean-Paul;
Allavena, Clotilde;
Aboulker, Jean-Pierre;
Molina, Jean-Michel

Publication type:

Article

Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration.

Published in:

PLoS Pathogens, 2017, v. 13, n. 7, p. 1, doi. 10.1371/journal.ppat.1006478

By:

Cardozo, E. Fabian;
Andrade, Adriana;
Mellors, John W.;
Kuritzkes, Daniel R.;
Perelson, Alan S.;
Ribeiro, Ruy M.

Publication type:

Article

Explaining the Determinants of First Phase HIV Decay Dynamics through the Effects of Stage-dependent Drug Action.

Published in:

PLoS Computational Biology, 2013, v. 9, n. 3, p. 1, doi. 10.1371/journal.pcbi.1002971

By:

Gilmore, James B.;
Kelleher, Anthony D.;
Cooper, David A.;
Murray, John M.

Publication type:

Article

Emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second-generation InSTIs in two- and three-drug regimens: the Virostar-1 study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2025, v. 80, n. 1, p. 95, doi. 10.1093/jac/dkae377

By:

Marcelin, Anne-Geneviève;
Soulie, Cathia;
Wirden, Marc;
Barriere, Guillaume;
Durand, François;
Charpentier, Charlotte;
Descamps, Diane;
Calvez, Vincent

Publication type:

Article

DORAVIR: a French national survey of people with HIV-1 treated with an antiretroviral regimen including doravirine.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 8, p. 1974, doi. 10.1093/jac/dkae194

By:

Soulie, Cathia;
Balde, Aliou;
Fofana, Djeneba;
Charpentier, Charlotte;
Bonnafous, Pascale;
Sourice, Justine;
Monte, Anne De;
Avettand-Fenoel, Véronique;
Guillou-Guillemette, Hélène Le;
Bocket, Laurence;
Raymond, Stéphanie;
Juillet, Stéphanie Marque;
Trabaud, Mary-Anne;
Montes, Brigitte;
Maillard, Anne;
Hartard, Cédric;
Alessandri-Gradt, Elodie;
Brochot, Etienne;
Signori-Schmuck, Anne;
Assoumou, Lambert

Publication type:

Article

Fostemsavir to overcome drug–drug interactions in heavily treatment-experienced people with HIV and cancer.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 7, p. 1708, doi. 10.1093/jac/dkae121

By:

Giacomelli, Andrea;
Cattaneo, Dario;
Pozza, Giacomo;
Moschese, Davide;
Cossu, Maria Vittoria;
Dalu, Davide;
Gervasoni, Cristina

Publication type:

Article

Correction to: Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.

Published in:: Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 6, p. 1471, doi. 10.1093/jac/dkae131
Publication type:: Article

Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1157, doi. 10.1093/jac/dkae086

By:

Chen, Guan-Jhou;
Cheng, Chien-Yu;
Yang, Chia-Jui;
Lee, Nan-Yao;
Tang, Hung-Jen;
Huang, Sung-Hsi;
Huang, Miao-Hui;
Liou, Bo-Huang;
Lee, Yi-Chien;
Lin, Chi-Ying;
Hung, Tung-Che;
Lin, Shih-Ping;
Sun, Hsin-Yun;
Chang, Sui-Yuan;
Hung, Chien-Ching;
Group, Taiwan HIV Study

Publication type:

Article

Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 5, p. 1142, doi. 10.1093/jac/dkae084

By:

Pang, Xianwu;
He, Qin;
Tang, Kailing;
Huang, Jinghua;
Fang, Ningye;
Xie, Haoming;
Ma, Jie;
Zhu, Qiuying;
Lan, Guanghua;
Liang, Shujia

Publication type:

Article

Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986–2020.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 287, doi. 10.1093/jac/dkad375

By:

Nduva, George M;
Otieno, Frederick;
Kimani, Joshua;
Sein, Yiakon;
Arimide, Dawit A;
Mckinnon, Lyle R;
Cholette, Francois;
Lawrence, Morris K;
Majiwa, Maxwell;
Masika, Moses;
Mutua, Gaudensia;
Anzala, Omu;
Graham, Susan M;
Gelmon, Larry;
Price, Matt A;
Smith, Adrian D;
Bailey, Robert C;
Medstrand, Patrik;
Sanders, Eduard J;
Esbjörnsson, Joakim

Publication type:

Article

Efficacy and safety of raltegravir plus lamivudine maintenance therapy.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 2, p. 255, doi. 10.1093/jac/dkad364

By:

Borjabad, Beatriz;
Inciarte, Alexy;
Chivite, Ivan;
Gonzalez-Cordon, Ana;
Mosquera, Mar;
Hurtado, Carmen;
Rovira, Cristina;
Gonzalez, Tania;
Sempere, Abiu;
Torres, Berta;
Calvo, Julia;
Mora, Lorena De La;
Martinez-Rebollar, Maria;
Laguno, Montserrat;
Foncillas, Alberto;
Ambrosioni, Juan;
Blanch, Jordi;
Rodriguez, Ana;
Solbes, Estela;
Llobet, Roger

Publication type:

Article

Impact of pretreatment low-abundance HIV-1 drug resistance on virological failure after 1 year of antiretroviral therapy in China.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2743, doi. 10.1093/jac/dkad297

By:

Li, Miaomiao;
Song, Chang;
Hu, Jing;
Dong, Aobo;
Kang, Ruihua;
Feng, Yi;
Xing, Hui;
Ruan, Yuhua;
Shao, Yiming;
Hong, Kunxue;
Liao, Lingjie

Publication type:

Article

Comment on: Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2780, doi. 10.1093/jac/dkad294

By:

Urbieta, Joaquín Bravo;
Belando, Sergio Alemán

Publication type:

Article

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11, p. 2696, doi. 10.1093/jac/dkad285

By:

Podzamczer, Daniel;
Imaz, Arkaitz;
Lopez-Lirola, Ana;
Knobel, Hernando;
Masiá, Mar;
Fanciulli, Chiara;
Hernández, Cristina;
Lagarde, María;
Gutierrez, Angela;
Curran, Adrià;
Morano, Luis;
Montero-Alonso, Marta;
Troya, Jesús;
Rigo, Raúl;
Casadellà, María;
Navarro-Alcaraz, Antonio;
Ardila, Fernando;
Parera, Mariona;
Bernal, Enrique;
Echeverria, Patricia

Publication type:

Article

Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 8, p. 2000, doi. 10.1093/jac/dkad195

By:

Abdullahi, Adam;
Kida, Ibrahim Musa;
Maina, Umar Abdullahi;
Ibrahim, Amina Husaini;
Mshelia, James;
Wisso, Haruna;
Adamu, Abdullahi;
Onyemata, James Ezenwa;
Edun, Martin;
Yusuph, Haruna;
Aliyu, Sani H;
Charurat, Man;
Abimiku, Alash'le;
Abeler-Dorner, Lucie;
Fraser, Christophe;
Bonsall, David;
consortium, PANGEA;
Kemp, Steven A;
Gupta, Ravindra K

Publication type:

Article

Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 7, p. 1711, doi. 10.1093/jac/dkad161

By:

Mandelbrot, Laurent;
Tubiana, Roland;
Frange, Pierre;
Peytavin, Gilles;
Chenadec, Jerome Le;
Canestri, Ana;
Morlat, Philippe;
Brunet-Cartier, Cécile;
Sibiude, Jeanne;
Peretti, Delphine;
Chambrin, Véronique;
Chabrol, Amélie;
Bui, Eida;
Simon-Toulza, Caroline;
Marchand, Lucie;
Paul, Christelle;
Delmas, Sandrine;
Avettand-Fenoel, Véronique;
Warszawski, Josiane;
group, the Monogest study

Publication type:

Article

HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 7, p. 1732, doi. 10.1093/jac/dkad163

By:

Duhant, Alexandra;
Kusinza, Byabene;
Tantet, Claire;
Bisimwa, Basimane;
Gare, Mathilde;
Masemo, Bihehe;
Alloui, Chakib;
Ntakwinjan, Mukanire;
Mechai, Frédéric;
Le, Minh Patrick;
Gerber, Athenaïs;
Muhigirwa, Balthazar;
Peytavin, Gilles;
Gordien, Emmanuel;
Brichler, Ségolène;
Mukwege, Mukengere;
Gal, Frédéric Le

Publication type:

Article

Four days/week antiretroviral maintenance strategy (ANRS 170 QUATUOR): substudies of reservoirs and ultrasensitive drug resistance.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1510, doi. 10.1093/jac/dkad119

By:

Lambert-Niclot, Sidonie;
Abdi, Basma;
Bellet, Jonathan;
Fofana, Djeneba;
Truchis, Pierre De;
Amat, Karine;
Alvarez, Jean-Claude;
Surgers, Laure;
Allavena, Clothilde;
Zaegell-Faucher, Olivia;
Morlat, Philippe;
Palich, Romain;
Gibowski, Séverine;
Costagliola, Dominique;
Girard, Pierre-Marie;
Landman, Roland;
Assoumou, Lambert;
Morand-Joubert, Laurence;
group, the ANRS 170 QUATUOR study

Publication type:

Article

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1423, doi. 10.1093/jac/dkad102

By:

Suárez-García, Inés;
Alejos, Belén;
Hernando, Victoria;
Viñuela, Laura;
García, Mar Vera;
Rial-Crestelo, David;
Elías, María Jesús Pérez;
Iglesias, Helena Albendín;
Peraire, Joaquim;
Tiraboschi, Juan;
Díaz, Asunción;
Moreno, Santiago;
Jarrín, Inma;
(CoRIS), the Cohort of the Spanish HIV/AIDS Research Network

Publication type:

Article

Increasing trend of transmitted integrase inhibitor resistance in a cohort of antiretroviral therapy-naive people living with HIV.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 5, p. 1314, doi. 10.1093/jac/dkad109

By:

Muccini, Camilla;
Galli, Laura;
Sampaolo, Michela;
Gianotti, Nicola;
Castagna, Antonella;
Canetti, Diana

Publication type:

Article

Drug resistance in children and adolescents with HIV in Panama.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 2, p. 423, doi. 10.1093/jac/dkac407

By:

Ventosa-Cubillo, Judit;
Pinzón, Ramón;
González-Alba, José María;
Estripeaut, Dora;
Navarro, María Luisa;
Holguín, África

Publication type:

Article